robotic surgery - 나만의 최고의 투자전략

Intuitive Surgical da Vinci 5 Procedure Growth Fears: Why a 40%+ Selloff Hands Long-Term Investors a Wide-Moat Compounder at 29x Forward Earnings

Intuitive Surgical (ISRG) da Vinci procedure growth fears drove a 40%+ selloff. At 29x forward earnings with a wide moat, here is why ISRG is a Buy.

미국 주식 분석

Intuitive Surgical’s da Vinci 80% Market Share Dominance: Why This Robotic Surgery Pioneer Commands a Premium Valuation

Intuitive Surgical dominates robotic surgery with 80% market share. Q1 2026 revenue surged 23% as da Vinci 5 adoption accelerates. Buy rating with $530 target.

미국 주식 분석

Intuitive Surgical Stock Analysis: The Robotic Surgery Pioneer Building an Unassailable Moat in the $30 Billion Surgical Automation Revolution

Intuitive Surgical stock analysis: ISRG dominates the B surgical robotics market with 67% share, da Vinci 5 Force Feedback technology, and 83% recurring revenue from 9,500+ installed systems.

[태그:] robotic surgery